| Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial DA Palma, R Olson, S Harrow, S Gaede, AV Louie, C Haasbeek, L Mulroy, ... The Lancet 393 (10185), 2051-2058, 2019 | 1572 | 2019 |
| Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials JY Chang, S Senan, MA Paul, RJ Mehran, AV Louie, P Balter, HJM Groen, ... The lancet oncology 16 (6), 630-637, 2015 | 1553 | 2015 |
| Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non–small-cell lung cancer FJ Lagerwaard, CJA Haasbeek, EF Smit, BJ Slotman, S Senan International Journal of Radiation Oncology* Biology* Physics 70 (3), 685-692, 2008 | 615 | 2008 |
| Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis S Senthi, FJ Lagerwaard, CJA Haasbeek, BJ Slotman, S Senan The lancet oncology 13 (8), 802-809, 2012 | 510 | 2012 |
| Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer FJ Lagerwaard, NE Verstegen, CJA Haasbeek, BJ Slotman, MA Paul, ... International Journal of Radiation Oncology* Biology* Physics 83 (1), 348-353, 2012 | 407 | 2012 |
| Stage I–II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a … NE Verstegen, JWA Oosterhuis, DA Palma, G Rodrigues, FJ Lagerwaard, ... Annals of oncology 24 (6), 1543-1548, 2013 | 323 | 2013 |
| Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer CJA Haasbeek, FJ Lagerwaard, BJ Slotman, S Senan Journal of Thoracic Oncology 6 (12), 2036-2043, 2011 | 289 | 2011 |
| Outcomes of stereotactic ablative radiotherapy for central lung tumours: a systematic review S Senthi, CJA Haasbeek, BJ Slotman, S Senan Radiotherapy and Oncology 106 (3), 276-282, 2013 | 280 | 2013 |
| Curative treatment of Stage I non-small-cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review D Palma, F Lagerwaard, G Rodrigues, C Haasbeek, S Senan International Journal of Radiation Oncology* Biology* Physics 82 (3), 1149-1156, 2012 | 226 | 2012 |
| Curative treatment of Stage I non-small-cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review D Palma, F Lagerwaard, G Rodrigues, C Haasbeek, S Senan International Journal of Radiation Oncology* Biology* Physics 82 (3), 1149-1156, 2012 | 226 | 2012 |
| Stage I nonsmall cell lung cancer in patients aged≥ 75 years: outcomes after stereotactic radiotherapy CJA Haasbeek, FJ Lagerwaard, ME Antonisse, BJ Slotman, S Senan Cancer: Interdisciplinary International Journal of the American Cancer …, 2010 | 203 | 2010 |
| Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial DA Palma, R Olson, S Harrow, RJM Correa, F Schneiders, CJA Haasbeek, ... BMC cancer 19, 1-15, 2019 | 190 | 2019 |
| Early-stage lung cancer in elderly patients: a population-based study of changes in treatment patterns and survival in the Netherlands CJA Haasbeek, D Palma, O Visser, FJ Lagerwaard, B Slotman, S Senan Annals of oncology 23 (10), 2743-2747, 2012 | 188 | 2012 |
| Radiological progression of cerebral metastases after radiosurgery: assessment of perfusion MRI for differentiating between necrosis and recurrence FWA Hoefnagels, FJ Lagerwaard, E Sanchez, CJA Haasbeek, DL Knol, ... Journal of neurology 256, 878-887, 2009 | 180 | 2009 |
| Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): study protocol for a randomized phase II trial DA Palma, CJA Haasbeek, GB Rodrigues, M Dahele, M Lock, B Yaremko, ... BMC cancer 12, 1-8, 2012 | 175 | 2012 |
| Outcomes of stereotactic ablative radiotherapy following a clinical diagnosis of stage I NSCLC: comparison with a contemporaneous cohort with pathologically proven disease NE Verstegen, FJ Lagerwaard, CJA Haasbeek, BJ Slotman, S Senan Radiotherapy and oncology 101 (2), 250-254, 2011 | 147 | 2011 |
| A prospective single-arm phase 2 study of stereotactic magnetic resonance guided adaptive radiation therapy for prostate cancer: early toxicity results AME Bruynzeel, SU Tetar, SS Oei, S Senan, CJA Haasbeek, ... International Journal of Radiation Oncology* Biology* Physics 105 (5), 1086-1094, 2019 | 144 | 2019 |
| Whole-brain radiotherapy with simultaneous integrated boost to multiple brain metastases using volumetric modulated arc therapy FJ Lagerwaard, EAP Van Der Hoorn, WFAR Verbakel, CJA Haasbeek, ... International Journal of Radiation Oncology* Biology* Physics 75 (1), 253-259, 2009 | 142 | 2009 |
| Patient-reported quality of life after stereotactic ablative radiotherapy for early-stage lung cancer FJ Lagerwaard, NK Aaronson, CM Gundy, CJA Haasbeek, BJ Slotman, ... Journal of Thoracic Oncology 7 (7), 1148-1154, 2012 | 125 | 2012 |
| Early prediction of tumor recurrence based on CT texture changes after stereotactic ablative radiotherapy (SABR) for lung cancer SA Mattonen, DA Palma, CJA Haasbeek, S Senan, AD Ward Medical physics 41 (3), 033502, 2014 | 124 | 2014 |
